Literature DB >> 16915009

Prognostic role of proton magnetic resonance spectroscopy in acute traumatic brain injury.

Lori Shutter1, Karen A Tong, Ann Lee, Barbara A Holshouser.   

Abstract

Proton magnetic resonance spectroscopy (MRS) is being used to evaluate individuals after acute traumatic brain injury. These studies have shown that changes in certain brain metabolites are associated with poor neurologic outcomes. The majority of MRS studies have been obtained relatively late after injury, but there have been a few reports of use early after injury to assist with outcome prediction. Altered brain metabolites may be sensitive indicators of injury and thus provide additional prognostic information when spectroscopy is done early after injury. This technology may provide a noninvasive means to evaluate early excitotoxic injury, and show changes associated with both neuronal injury and membrane disruption secondary to diffuse axonal injury. This article will review the technology of MRS, discuss its role in patient assessment after traumatic brain injury, and present a summary of our published and ongoing research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16915009     DOI: 10.1097/00001199-200607000-00005

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  13 in total

Review 1.  Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder.

Authors:  Robert W Van Boven; Greg S Harrington; David B Hackney; Andreas Ebel; Grant Gauger; J Douglas Bremner; Mark D'Esposito; John A Detre; E Mark Haacke; Clifford R Jack; William J Jagust; Denis Le Bihan; Chester A Mathis; Susanne Mueller; Pratik Mukherjee; Norbert Schuff; Anthony Chen; Michael W Weiner
Journal:  J Rehabil Res Dev       Date:  2009

2.  [Craniocerebral trauma: magnetic resonance imaging of diffuse axonal injury].

Authors:  A Mallouhi
Journal:  Radiologe       Date:  2014-09       Impact factor: 0.635

Review 3.  1H-MR spectroscopy in traumatic brain injury.

Authors:  Silvia Marino; Rosella Ciurleo; Placido Bramanti; Antonio Federico; Nicola De Stefano
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

4.  Management of traumatic brain injury.

Authors:  Andrew Losiniecki; Lori Shutter
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.598

5.  Longitudinal Metabolite Changes after Traumatic Brain Injury: A Prospective Pediatric Magnetic Resonance Spectroscopic Imaging Study.

Authors:  Barbara Holshouser; Jamie Pivonka-Jones; Joy G Nichols; Udo Oyoyo; Karen Tong; Nirmalya Ghosh; Stephen Ashwal
Journal:  J Neurotrauma       Date:  2018-12-20       Impact factor: 5.269

6.  Neurometabolite concentrations in gray and white matter in mild traumatic brain injury: an 1H-magnetic resonance spectroscopy study.

Authors:  Charles Gasparovic; Ronald Yeo; Maggie Mannell; Josef Ling; Robert Elgie; John Phillips; David Doezema; Andrew R Mayer
Journal:  J Neurotrauma       Date:  2009-10       Impact factor: 5.269

7.  Global brain metabolic quantification with whole-head proton MRS at 3 T.

Authors:  Ivan I Kirov; William E Wu; Brian J Soher; Matthew S Davitz; Jeffrey H Huang; James S Babb; Mariana Lazar; Girish Fatterpekar; Oded Gonen
Journal:  NMR Biomed       Date:  2017-07-05       Impact factor: 4.044

8.  Imaging of glutamate in acute traumatic brain injury using chemical exchange saturation transfer.

Authors:  Yifei Mao; Zerui Zhuang; Yanzi Chen; Xiaolei Zhang; Yuanyu Shen; Guisen Lin; Renhua Wu
Journal:  Quant Imaging Med Surg       Date:  2019-10

9.  Proton MR spectroscopy in mild traumatic brain injury.

Authors:  Bożena Kubas; Wojciech Lebkowski; Urszula Lebkowska; Wojciech Kułak; Eugeniusz Tarasow; Jerzy Walecki
Journal:  Pol J Radiol       Date:  2010-10

10.  Metabolic changes in concussed American football players during the acute and chronic post-injury phases.

Authors:  Luke C Henry; Sébastien Tremblay; Suzanne Leclerc; Abdesselam Khiat; Yvan Boulanger; Dave Ellemberg; Maryse Lassonde
Journal:  BMC Neurol       Date:  2011-08-23       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.